Ticker Symbol: QURE
uniQure N.V.
$31.06 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001590560
Company Profile
uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary gene therapies to treat patients with hemophilia B, Huntington's disease, Fabry disease, spinocerebellar ataxia Type 3 and other diseases.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: www.uniqure.com
CEO: N/A
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $6.33
Change:
$0.15
(
2.43%)
Days Range: $5.98 - $6.36
Beta: 1.18
52wk. High: $28.26
52wk. Low: $5.95
Ytd. Change -70.31%
50 Day Moving Average: $6.99
200 Day Moving Average: $13.03
Shares Outstanding: 47803193
Valuation
Market Cap: 30.2B
PE Ratio: -1.60
EPS (TTM): -3.96
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A